SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001019056-21-000500
Filing Date
2021-09-23
Accepted
2021-09-23 16:54:53
Documents
2
Group Members
GIL AHARONROSALIND ADVISORS, INC.ROSALIND MASTER FUND L.P.STEVEN SALAMON

Document Format Files

Seq Description Document Type Size
1 SC 13G unicycive_13g.htm SC 13G 132594
2 EXHIBIT A ex_a.htm EX-99.A 7231
  Complete submission text file 0001019056-21-000500.txt   141464
Mailing Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8
Business Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1130
Type: SC 13G

Mailing Address 5150 EL CAMINO REAL, SUITE A-32 LOS ALTOS CA 94022
Business Address 5150 EL CAMINO REAL, SUITE A-32 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Subject) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92874 | Film No.: 211273069
SIC: 2834 Pharmaceutical Preparations